Previous Close
$6.96
Day Range
$0 - $0
Previous Day Range
$6.51 - $7.03
Market Cap
$369.4 million USD
Day Vol.
0
Previous Day Vol.
1.1 million
Currency
USD
Primary Exchange
Nasdaq
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule ...
Community
- 0 posts discussing
0
Watchers
0
Visitors
Recent News
Trending Tickers
Please sign in to view